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Abstract
Background: Malnutrition is a common consequence of disease in older patients. Both in hospital setting and in
community setting oral nutritional support has proven to be effective. However, cost-effectiveness studies are
scarce. Therefore, the aim of our study is to investigate the effectiveness and cost-effectiveness of transmural
nutritional support in malnourished elderly patients, starting at hospital admission until three months after
discharge.
Methods: This study is a randomized controlled trial. Patients are included at hospital admission and followed until
three months after discharge. Patients are eligible to be included when they are ≥ 60 years old and malnourished
according to the following objective standards: Body Mass Index (BMI in kg/m
2) < 20 and/or ≥ 5% unintentional
weight loss in the previous month and/or ≥ 10% unintentional weight loss in the previous six months. We will
compare usual nutritional care with transmural nutritional support (energy and protein enriched diet, two
additional servings of an oral nutritional supplement, vitamin D and calcium supplementation, and consultations by
a dietitian). Each study arm will consist of 100 patients. The primary outcome parameters will be changes in
activities of daily living (determined as functional limitations and physical activity) between intervention and
control group. Secondary outcomes will be changes in body weight, body composition, quality of life, and muscle
strength. An economic evaluation from a societal perspective will be conducted alongside the randomised trial to
evaluate the cost-effectiveness of the intervention in comparison with usual care.
Conclusion: In this randomized controlled trial we will evaluate the effect of transmural nutritional support in
malnourished elderly patients after hospital discharge, compared to usual care. Primary endpoints of the study are
changes in activities of daily living, body weight, body composition, quality of life, and muscle strength. An
economic evaluation will be performed to evaluate the cost-effectiveness of the intervention in comparison with
usual care.
Trial registration: Netherlands Trial Register (ISRCTN29617677, registered 14-Sep-2005)
Background
The primary cause of malnutrition in developed coun-
tries is disease. Malnutrition is estimated to occur in 25-
61% of all elderly patients suffering from a variety of
diseases [1,2]. Unintentional weight loss of ≥ 5% in the
previous month and/or unintentional weight loss of ≥
10% in the previous six months and/or a BMI <20 kg/
m
2 are often used as parameters to identify
malnutrition.
Disease related malnutrition is associated with adverse
effects on clinical outcome, as has been shown in a
large number of studies. These adverse effects vary from
impaired wound healing and postoperative complica-
tions to mortality [3]. Poor nutritional status has not
only been associated with in-hospital adverse effects, but
also with adverse effects both pre-admission and post-
discharge. These effects include a trend for increased
need for re-hospitalization, significantly higher total
mortality, a higher general practitioner consultation rate,
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tion, an increased need for nursing home admission,
increased likelihood of requiring home health care after
discharge and early institutionalization [4,5].
So far, randomized clinical trials have shown that
additional Oral Nutritional Support (ONS) can be effec-
tive in malnourished elderly people, both in the clinical
setting and in the community [6]. In hospitalized
patients ONS has been shown to reduce weight loss, to
shorten hospital stay and to improve functional status in
malnourished hospitalized patients. In the community
ONS has been shown to increase activities of daily liv-
ing, to reduce the number of falls and to reduce health
care utilization [5,7-10].
Furthermore, a meta-analysis, including 31 studies and
almost 2500 patients, showed that protein and energy
supplementation led to small changes in weight and,
more importantly to reduced mortality (RR 0,67; CI
0,52-0,87). Also, length of hospital stay was reduced by
on average 3.3 days (CI -9.64-3.05) [7].
Because nowadays patients spend only a minority of
time in hospital and recover at home, it is not very
likely that patients’ nutritional status will improve dur-
ing the short period of admission. Therefore, the pro-
blem of disease related malnutrition is more and more
becoming a post-discharge problem (in this manuscript
further referred to as a transmural problem).
For in-hospital patients, studies on cost-effectiveness
of nutritional interventions are scarce. In a retrospective
cost-analysis of nine randomized controlled trials on
nutritional support, the cost savings aggregated between
€503 and €11696 per patient in surgical, orthopedic,
elderly and stroke patients [6]. A recent observational
cohort study showed a cost reduction in patients sup-
plied with ONS of €723 per patient [8]. In a prospective
study, a reduction of length of hospital stay with one
day was achieved with an investment of €34 per mal-
nourished patient [11].
Cost-effectiveness studies of ONS in the community
are lacking and are eagerly awaited for. We do expect
that a nutritional intervention in the transmural setting
will be accompanied by higher health care costs than
usual care, but that these higher costs are negligible
compared with the cost-savings they can potentially
generate.
The aim of this study is to investigate the cost-effec-
tiveness of transmural nutritional support in malnour-
ished elderly patients after hospital discharge as
compared to usual care on changes in activities of daily
living. Secondary outcomes include changes in body
weight, body composition, quality of life, and muscle
strength between intervention and control group.
Methods
Design
This study is designed as a randomized controlled trial
comparing transmural nutritional support with usual
nutritional care. The study design is in accordance with
the Declaration of Helsinki and has been approved by
the Medical Ethics Committee (METC) of VU Univer-
sity Medical Center.
Patients are eligible for this study when they are ≥ 60
years old and malnourished according to the following
objective standards: Body Mass Index (BMI in kg/m
2)<
20 and/or, ≥ 5% unintentional weight loss in the pre-
vious month and/or ≥ 10% unintentional weight loss in
the previous six months. We will compare usual nutri-
tional care with transmural nutritional support (energy
and protein enriched diet, two additional servings of an
oral nutritional supplement, vitamin D and calcium sup-
plementation, and consultations by a dietitian). The pri-
mary outcome parameters will be changes in activities
of daily living (functional limitations and physical activ-
ity) between the intervention and control group. Sec-
ondary outcomes will be changes in body weight, body
composition, quality of life, and muscle strength. An
economic evaluation from a societal perspective will be
conducted alongside the randomised trial to evaluate
the cost-effectiveness of the intervention versus usual
care.
Feasibility of recruitment and sample size
Earlier studies have shown that 30% of the elderly hospi-
tal population is malnourished at admission [12-16]. For
a clinically relevant difference of 20% in nutritional and
functional status with a statistical significance level of
0.05 and a power of 80%, two groups of 80 patients
were calculated to be sufficient.
A pilot study showed that inclusion of 140 malnour-
ished patients per year is feasible. Taking into account
an expected refusal rate of 30% at inclusion and loss to
follow-up of 10% during the three months following dis-
charge, we aim to include two groups of 100, to be
reached in approximately two years.
Randomisation
A computerized random number generator will be used
to assign patients either to the intervention group or the
control group. Patients will be randomized in blocks of
ten. At the end of the baseline interview and measure-
ments, the primary investigator opens a consecutively
numbered opaque envelope containing the patients’
group assignment. Participants, research assistant and
researcher are no longer blinded for the intervention
from this point. Before starting the analyses the
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assignment.
Population, inclusion and exclusion criteria
All elderly patients (≥ 60 years of age, expected length
of hospital admission >2 days) newly admitted to the
wards of internal medicine, traumatology and vascular
surgery of the VU University Medical Center will be
screened at admission by a dietitian and/or research
assistants of nutritional status. These departments repre-
sent the (sub)specialties general internal medicine, rheu-
matology, gastroenterology, dermatology, nephrology,
orthopedics, traumatology and vascular surgery.
Patients will be excluded from the study when they
suffer from senile dementia, can not understand the
Dutch language or are not able to or willing to give
informed consent.
Nutritional status
Patients are be eligible for this study if they are identi-
fied malnourished according to the following criteria:
￿ Body Mass Index (BMI in kg/m
2) < 20 and/or
￿ ≥ 5% unintentional weight loss in the previous
month and/or
￿ ≥ 10% unintentional weight loss in the previous six
months.
Weight (in kg to the nearest decimal) is measured
(with patients wearing light indoor clothes and no
shoes) on a calibrated chair scale (Prior MD-1512), with
an accuracy of 0.1 kilogram, at admission and three
months after discharge. A correction factor for clothes
will be made by deducting weight with 2.0 kilograms for
men and 1.3 kilograms for women [17].
BMI is calculated as actual weight in kilograms
divided by the square of height in meters.
As measurement of height is often not feasible in this
ill, old and frail population, data on height will be
retrieved from self-reported height, with an accuracy of
1.0 centimeter. These data will be validated against
height derived from knee height measurements (Seca
207, in cm to the nearest decimal) in approximately 800
elderly patients from the same departments at our
institute.
Intervention
Control patients will receive ‘usual’ nutritional care, i.e.
hospital intervention only on referral by the treating
physician and without standardized transmural nutri-
tional support.
Patients assigned to the intervention group strategy
will receive standardized transmural nutritional support
(Appendix 1) starting in hospital and to be continued
until three months after discharge.
Procedure
After obtaining patients’ informed consent an inventory
will be made of nutritional status, nutritional risk profile
and possible confounders. This includes the following
baseline characteristics:
- sociodemographic data (age, gender, education
level, partner status)
- medical history and medical diagnosis
- anthropometry (weight, height, BMI, percentage
involuntary weight loss)
- biochemical parameters (CRP, IGF-1, 25(OH)D)
- mental state (MMSE) [18]
- expected care complexity (COMPRI) [19]
Information on disease, disease severity, disease
course, treatment and complications will be retrieved
from medical records.
Post-discharge practice will be followed and outcome
parameters will be collected for all patients at three
months after discharge.
Outcome parameters
Outcome parameters will be measured after inclusion
and at three months after discharge.
Primary outcome is change in activities of daily living,
determined as functional limitations and physical activ-
ities. All outcome parameters that will be measured are
listed below.
Activities of daily living
Activities of daily living (ADL) will be assessed with a
validated questionnaire that measures the degree of dif-
ficulties patients experience with six activities: climbing
stairs, walking 5 minutes outdoors without resting, get-
ting up and sitting down in a chair, dressing and
undressing oneself, using own or public transportation,
and cutting one’s own toenails [20]. Functional limita-
tions will be assessed using five difficulty categories, ran-
ging from “No I can not’ to ‘Yes without difficulty’.
Total score will be calculated by summing the scores of
all activities, ranging from 0 (does not have any difficul-
ties with the activities) to 6 (has difficulties with all
activities).
Physical performance
The performance test of physical function includes time
measures of walking speed, rising from a chair, putting
on and taking off a cardigan, and maintaining balance in
a tandem stand [21-23]. To test walking performance a
3 meter walking course is created by a measuring line.
Patients are instructed to walk to the other end of the
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possible. Patients are allowed to use a walking aid if
necessary. To test the ability to rise from a chair,
patients are asked to fold their arms across their chest
and to stand up and sit down five times from a standard
hospital chair as quickly as possible. For the cardigan
test, patients are asked to put on and take off a cardigan
as quickly as possible. To test for balance, patients are
asked to stand with one foot placed behind the other in
a straight line for at least 10 seconds.
A trained research assistant records the total time
needed to complete each test.
Patients who complete the walking test, chair test and
cardigan test will be assigned scores between 1 and 4,
corresponding to the quartiles of time needed to com-
plete the test, with the fastest time scored as 4. Those
who cannot complete the test will be assigned a score of
0. Accordingly the maximum score for these three tests
ranges from 0-12 points, after adding up the result of
these tree tests.
The balance test will be analyzed separately, yet with
the same time classification as described above.
Physical activity
Physical activity will be assessed with the validated
LASA Physical Activity Questionnaire (LAPAQ) [24].
This face-to-face questionnaire covers the frequency and
duration of walking outside, cycling, gardening, sports
and household activities during the previous two weeks.
Walking and bicycling for transportation purposes are
considered as common daily activities in The Nether-
lands, and not as sports activities. For the analyses, the
total time spent on physical activity of the last two
weeks is used (in minutes per day).
Quality of life
Quality of Life will be measured by the SF-12 and Euro-
Qol (EQ-5D and EQ-VAS).
The SF-12 contains 12 questions from the SF-36 [25].
These questions concern functional status -both physical
and social functioning-mental health, pain, vitality and
evaluation of persons’ state of health. With these dimen-
sions two total scores can be calculated; one physical
component score and one mental component score [26].
EuroQol (EQ-5D) is a standardised instrument to
monitor health outcome [27]. This instrument contains
five short questions on mobility, self-care, daily activ-
ities, pain/discomfort and anxiety/depression with three
possible response categories (no problems, moderate
p r o b l e m s ,s e v e r ep r o b l e m s ) .T h eE Q - 5 Ds c o r e sw e r e
used to calculate utilities using the Dutch tariff [28].
QALYs were calculated by multiplying the utilities with
the amount of time a patient spent in a particular health
state. Transitions between health states were linearly
interpolated.
Additionally we will administer the EQ VAS. The EQ-
VAS, a visual analog scale, generates a self-rating of
health-related quality of life. The patient rates his/her
h e a l t hs t a t eb yd r a w i n gal i n ef r o mt h eb o xm a r k e d
“Your health state today” to the appropriate point on
the EQ-VAS on a scale of 0 to 100.
Hand grip strength
Hand grip strength (in kg) will be measured with a
hydraulic hand dynamometer (Baseline, Fabrication
Enterprises Inc., Elmsford, NY, USA). Respondents are
asked to perform two maximum force trials with their
non-dominant hand. The highest value will be used.
Measured data will be compared to reference values by
Mathiowetz. Data will be expressed as percentage of
reference value [29].
Fall-incidents
Patients will be asked to report all fall incidents weekly
in a fall diary for a period of three months after dis-
charge. A fall is defined as “an unintentional change in
position resulting in coming to rest at a lower level or
on the ground” [30].
Bio-electrical impedance spectroscopy
Bio-electrical impedance spectroscopy (BIS) will be
applied to calculate (changes in) body composition.
Measurements will be performed at the non-dominant
side of the patient, using a Hydra ECF/ICF Bio Impe-
dance Spectrum Analyzer, model 4200 (Xitron Technol-
ogies, San Diego, CA, USA). Shoes, socks and jewellery
will be removed and patients will be in supine position.
Two current electrodes (tetra-polar electrodes (3 M red
Dot AG/AgCl)) will be placed at the dorsal surfaces of
the hand and foot on the distal position of the second
metacarpal and metatarsal, respectively. Two detector
electrodes will be placed at the posterior wrist between
the styloid processes of the radius and ulna and at the
ankle between the tibial and fibular malleoli. With this
technique, two body compartments, fat mass (FM) and
fat free mass (FFM), can be determined. Patients with a
pacemaker will be excluded from this measurement.
Resting energy expenditure
Resting energy expenditure (REE) will be calculated
from measurements of oxygen consumption (VO2)a n d
carbon dioxide production (VCO2) by with a ventilated
hood system, in supine position for 30 minutes, with a
metabolic monitor (Vmax Encore n29, Viasys Health-
care, Houten, The Netherlands). Before each measure-
ment, gas analyzers will be calibrated with two reference
g a sm i x t u r e s( a .1 6 %O 2,4 %C O 2,b a l .N 2 and b. 26%
O2,b a l .N 2. (Viasys)). Patients will be monitored during
the measurement to prevent movements or sleeping
under the hood.
REE will be calculated from oxygen consumption and
carbon dioxide production by using the equation of
Weir [31].
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Dietary intake will be obtained by asking in broad out-
lines for patients’ m e a nd a i l yi n t a k eo ff o o da n dd r i n k s
in the two weeks before admission to the hospital and
at three months after discharge.
Biochemical parameters CRP, IGF-1, 25(OH)D
Two blood samples per patient will be obtained: the first
on the day after inclusion and the second three months
after discharge. We will measure CRP, IGF-1 and 25
(OH)D in both samples. The blood samples will be cen-
trifuged and stored at -80°C. All blood samples will be
analyzed simultaneously after completing full data
collection.
C-reactive proteïn (CRP in mg/l) is a member of the
class of acute-phase reactants as its levels rise dramati-
cally during inflammation processes. Plasma concentra-
tions of C-Reactive Protein (CRP) will be measured with
an automated latex-enhanced immunoturbidimetric
assay on a Modular P800 analyzer (Roche Diagnostics,
Almere, The Netherlands).
Insuline-like growth factor (IGF-1 in μg/l) will be
obtained to observe over or under production of
growth-hormone. Serum levels of IGF-1 will be mea-
sured with a Immulite 2500 analyzer (Siemens, Deer-
field, IL, USA)
Serum 25(OH)D (in nmol/l) will be obtained to
observe differences in vitamin D levels after the three
month supplementation of vitamin D in the intervention
group. This will be determined using a competitive pro-
tein binding assay (Nichols Diagnostics, San Juan Capis-
trano, CA, USA).
All analyses will be performed at department of Clini-
cal Chemistry of the VU University Medical Center.
Costs
Costs will be measured from a societal perspective.
Direct health care costs include the costs of transmural
nutritional support (nutritional supplements plus dieti-
tian), hospitalization, additional visits to other health
care providers (general practitioner, medical specialist),
prescription and over-the-counter medication, profes-
sional home care. Direct non-health care costs of paid
and unpaid help and indirect cost of absenteeism of
paid and unpaid work will also be included.
Data on the use of nutritional support will be regis-
tered by the dietician implementing the transmural
nutritional intervention. Data on health care utilization
during hospitalization will be retrieved from medical
records and the hospital information system. Use of
other health care resources after discharge from the hos-
pital will be collected through two identical cost diaries
each spanning a period of 6 weeks. Medication data will
be obtained from the patients’ pharmacies.
Health care utilization will be valued using standard
costs from the Dutch guidelines for cost analysis in
health care research [32]. If there are no standard costs
available, tariffs or prices from health care providers
themselves or professional organizations will be used.
The costs of medication will be estimated on the basis
of prices charged by the Royal Dutch Society for
Pharmacy.
Economic evaluation
The aim of the economic evaluation will be to deter-
mine and compare the total costs for patients receiving
either transmural nutritional support or usual care, and
to relate these costs to the effects of the interventions.
Incremental cost-effectiveness ratios (ICERs) will be
calculated by dividing the difference in mean total costs
between the two interventions by the difference in mean
effects between the two interventions. The ICERs will be
calculated for the primary clinical effect measures of the
trial, i.e. functional status and ADL. Cost-utility ratios
will also be calculated.
Bootstrapping will be used for pair-wise comparison of
the mean differences in total costs between the interven-
tion groups. Confidence intervals will be obtained by
bias corrected and accelerated (Bca) bootstrapping using
5000 replications [33]. To estimate the uncertainty sur-
rounding the ICERs bias corrected accelerated boot-
strapping (5000 replications) will be used. The
bootstrapped cost-effect pairs will be plotted on cost-
effectiveness planes and will be used to estimate cost-
effectiveness acceptability curves.
Organization
The primary investigator is responsible for the informed
consent procedure, final patient selection, measure-
ments, analysis and reports. The primary investigator
will be assisted by a research assistant.
Data flow will be controlled by the primary investiga-
tor, using an administrative database system. Data-entry
and control will be conducted by a research assistant
under supervision of the investigator. The primary
investigator is responsible for the data cleaning and
analysis.
Statistical analyses
All analyses will be performed according to the inten-
tion-to-treat principle. 95% confidence intervals will be
calculated for the differences in percentages and means.
Logistic regression will be used to analyze dichotomous
variables, Poisson regression for the count-variables and
linear regression for continuous variables. Ceiling and
floor effects will be taken into account in the analysis of
the questionnaires.
In order to test the independent contribution of the
intervention on the outcome variables, multivariate
regression analysis will be used to adjust for the possible
confounders.
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When designing the study protocol we had to make a
number of considerations, which may lead to the follow-
ing strengths and weaknesses:
Firstly, we have chosen a strict definition of malnutri-
tion, because the most malnourished group is most
likely to benefit from oral nutritional support. Since we
have used the described cut-off points for malnutrition
in previous studies as well, we expect that it is feasible
to include a sufficient number of patients in the pro-
posed study.
Secondly, we have chosen not to use strict exclusion
criteria, but to include all eligible patients, even though
they are suffering from a variety of (chronic) diseases.
Their homogeneity stems from their age (>60y), degree
of malnutrition (severe malnutrition) and background of
disease (mainly non-surgical). We have performed ear-
lier studies with this same group of relatively unselected
patients with positive results of the nutritional interven-
tion (after correcting for possible confounders such as
age, sex, ethnicity, care complexity, disease etc) in com-
parison with usual care [11,34]. Moreover, if the results
o fab r o a ds t u d yl i k et h i so n ea r ep o s i t i v e ,i tj u s t i f i e s
wide implementation, because the included group is
representative for a mixed elderly hospital population; in
contrast, selection of a more specific group would make
the intervention less applicable to other patients groups.
Thirdly, for research purposes, standardized oral nutri-
tional supplementation is chosen because simply advis-
ing patients to increase their intake by eating more has
not proven to be a solution that can be relied on. From
earlier studies, it is known that providing extra supple-
ments does increase energy intake and leads to weight
gain, in contrast to dietary advice alone (without extra
supplements) [10,35-37].
Fourthly, the follow-up period of three months is cho-
sen because this seems a reasonable recovery period
after discharge in this particular patient group. Also, it
is known that compliance of patients to take extra sup-
plements diminishes after three months [38,39]. By mak-
ing regular phone calls to the patients we try to
maintain compliance.
Fifthly, care should be taken of in-hospital contamina-
tion between treatment groups. The majority of in-hos-
pital patients will not be supplemented additional
nutrition, either because they are not malnourished (±
70%) or because they are randomized to the control
strategy (50% of the study population, 15% of the total
population). Except for the primary investigator and
research assistant, doctors and nurses will not be aware
of the reason for not-supplementing. Thus we expect to
be able to prevent contamination between treatment
groups. In addition, hospital admission will last only 10
to 15 days and post-discharge treatment will be approxi-
mately three months. We expect that the post-discharge
period to account for the majority of the effects. Con-
tamination between treatment groups in not likely to
occur after discharge.
Finally, this is the first prospective, randomized con-
trolled trial evaluating whether transmural nutritional
support is effective and cost-effectiveness when com-
pared to usual care.
Conclusion
In this study we will evaluate in a randomized con-
trolled trial whether transmural nutritional support,
compared to usual care, is effective and cost-effective, in
malnourished elderly patients. We will determine
changes in activities of daily living, physical activity,
functional limitations, body weight, body composition,
quality of life, and muscle strength between the inter-
vention and control group during the period between
admission to hospital and three months after discharge.
Appendix 1
Standardised transmural nutritional support in the inter-
vention group:
- Energy and protein enriched diet (in-hospital
period)
- Two additional servings of an oral nutritional sup-
plement, leading to an expected increase in intake of
± 600 kcal/day and 24 g protein/day per day (entire
study period)
- 400 IE vitamin D3 and 500 mg calcium (Calci
Chew-D3, Sandoz) per day (entire study period)
- Six consultations by telephone by a dietitian in
order to give advice and to stimulate compliance to
the proposed nutritional intake (every other week
after discharge from the hospital)
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